These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28672282)

  • 21. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection.
    Rodrigues R; Barber GE; Ananthakrishnan AN
    Infect Control Hosp Epidemiol; 2017 Feb; 38(2):196-202. PubMed ID: 27817758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National age group trends in Clostridium difficile infection incidence and health outcomes in United States Community Hospitals.
    Pechal A; Lin K; Allen S; Reveles K
    BMC Infect Dis; 2016 Nov; 16(1):682. PubMed ID: 27855653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
    Finn E; Andersson FL; Madin-Warburton M
    BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection.
    Saha S; Mara K; Pardi DS; Khanna S
    Clin Infect Dis; 2021 Oct; 73(7):e1706-e1712. PubMed ID: 32976567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Clostridioides difficile Infection Among Asymptomatic, Colonized Patients: A Retrospective Cohort Study.
    Poirier D; Gervais P; Fuchs M; Roussy JF; Paquet-Bolduc B; Trottier S; Longtin J; Loo VG; Longtin Y
    Clin Infect Dis; 2020 May; 70(10):2103-2210. PubMed ID: 31290544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of bezlotoxumab to prevent recurrent Clostridioides difficile infection (CDI) in patients with multiple prior recurrent CDI.
    Skinner AM; Tan X; Westman C; Birris T; Drwiega EN; Wang MS; Johnson S
    Anaerobe; 2023 Dec; 84():102788. PubMed ID: 37931679
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Cortés P; Bi Y; Stancampiano F; Valery JR; Cooper JH; Harris DM
    Rom J Intern Med; 2021 Sep; 59(3):262-269. PubMed ID: 33713592
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial.
    Sims MD; Khanna S; Feuerstadt P; Louie TJ; Kelly CR; Huang ES; Hohmann EL; Wang EEL; Oneto C; Cohen SH; Berenson CS; Korman L; Lee C; Lashner B; Kraft CS; Ramesh M; Silverman M; Pardi DS; De A; Memisoglu A; Lombardi DA; Hasson BR; McGovern BH; von Moltke L;
    JAMA Netw Open; 2023 Feb; 6(2):e2255758. PubMed ID: 36780159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Active surveillance pharmacovigilance for Clostridioides difficile infection and gastrointestinal bleeding: an analytic framework based on case-control studies.
    Vajravelu RK; Byerly AR; Feldman R; Rothenberger SD; Schoen RE; Gellad WF; Lewis JD
    EBioMedicine; 2024 May; 103():105130. PubMed ID: 38653188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.
    Alonso CD; Treadway SB; Hanna DB; Huff CA; Neofytos D; Carroll KC; Marr KA
    Clin Infect Dis; 2012 Apr; 54(8):1053-63. PubMed ID: 22412059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?
    Allegretti JR; Kao D; Phelps E; Roach B; Smith J; Ganapini VC; Kassam Z; Xu H; Fischer M
    Dig Dis Sci; 2019 Jun; 64(6):1668-1671. PubMed ID: 30632052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Observational Cohort Study of
    Rao K; Higgins PDR; Young VB
    mSphere; 2018; 3(3):. PubMed ID: 29794054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical practice guidelines for Clostridioides (Clostridium) difficile infection and fecal microbiota transplant protocol - recommendations of the Polish Society od Epidemiology and Infectious Diseases.
    Piekarska A; Panasiuk A; Stępień PM
    Przegl Epidemiol; 2020; 74(1):69-87. PubMed ID: 32500988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk and Outcomes of Clostridium difficile Infection With Chronic Pancreatitis.
    Adejumo AC; Adejumo KL; Pani LN
    Pancreas; 2019 Sep; 48(8):1041-1049. PubMed ID: 31404028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridioides difficile Infection in Children With Inflammatory Bowel Disease.
    Chandrakumar A; Zohni H; El-Matary W
    Inflamm Bowel Dis; 2020 Oct; 26(11):1700-1706. PubMed ID: 31765471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factors that Predict Recurrent Clostridium difficile Infections in Surgical Patients.
    Messick CA; Hammel JP; Hull T
    Am Surg; 2017 Jun; 83(6):653-659. PubMed ID: 28637570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of Clostridioides difficile infections among young and middle-aged adults: Veterans Health Administration.
    Russo EM; Kuntz J; Yu H; Smith J; Hauser RG; Halchenko Y; Young-Xu Y
    Infect Control Hosp Epidemiol; 2019 Sep; 40(9):997-1005. PubMed ID: 31322101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in the Incidence and Outcomes of Hospitalized Cancer Patients With
    Gupta A; Tariq R; Frank RD; Jean GW; Beg MS; Pardi DS; Johnson DH; Khanna S
    J Natl Compr Canc Netw; 2017 Apr; 15(4):466-472. PubMed ID: 28404757
    [No Abstract]   [Full Text] [Related]  

  • 39. Microbiota restoration for recurrent Clostridioides difficile: Getting one step closer every day!
    Khanna S
    J Intern Med; 2021 Aug; 290(2):294-309. PubMed ID: 33856727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Québec, Canada.
    Lavallée C; Labbé AC; Talbot JD; Alonso CD; Marr KA; Cohen S; Laverdière M; Dufresne SF
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.